Rich source of documentation, tools, & background technologies to help enable & accelerate your research & drug discovery & development programs.
Eurofins DiscoverX and Eurofins BioPharma Product Testing are partnering at this years EU BEBPA conference in Netherlands. Gaurav Agrawal, Ph.D. (
...Show MoreThe non-receptor protein tyrosine phosphatase (PTP) SHP2 is encoded by the proto-oncogene PTPN11 and is a ubiquitously expressed key regulator…
...Show MoreLearn about the first commercially available SIRPα/CD47 cell-based assay — PathHunter SIRPα Signaling Assay. Find out more about the generation…
...Show MoreG-protein-coupled receptors (GPCRs) have varying and diverse physiological roles, transmitting signals from a range of stimuli, including light, ch
...Show MoreA Potent, Selective and Cell-Active Allosteric Inhibitor of Protein Arginine Methyltransferase 3 (PRMT3)
Why Analytical Development of Agonistic Antibodies Remains Challenging? A Comprehensive Strategy to Unlock Their Characterization for Immunotherapy
...Show MoreA quantitative and robust bioassay that is reflective of the MOA of the drug is a critical component of any…
Learn how functional cell-based assays support COVID-19 drug discovery programs, particularly in managing proinflammatory cytokines associated with
...Show MoreProgressing Biotherapeutics to Clinic Faster Biological activity of a biotherapeutic is a Critical Quality Attribute (CQA), which needs to be accur
...Show MoreEurofins DiscoverX, in conjunction with Drug Target Review, sponsored and moderated a Bioassay roundtable discussion webinar with group leaders fro
...Show MoreCOVID-19 has been declared a global pandemic by WHO. The disease is transmitted when the SARS-CoV-2 virus infects the respiratory…
Cytokines and their receptors have emerged as major drug targets for inflammatory and autoimmune diseases, allergies, and, more recently, in cancer
...Show More